Literature DB >> 8660156

Frequency of dementia in Parkinson disease.

D Aarsland1, E Tandberg, J P Larsen, J L Cummings.   

Abstract

OBJECTIVE: To investigate the frequency of dementia in patients with Parkinson disease (PD).
DESIGN: Community-based prevalence study.
SETTING: The study population comprised 220,858 inhabitants from the Rogaland County, Norway. PARTICIPANTS: Almost 400 participants were examined by a neurologist, and 245 were given the diagnosis of PD and included in the study. MEASUREMENTS: Mental functioning was rated with the Mini-Mental State Examination; Gottfries, Bråne, and Steen scale; and the intellectual subscale of the Unified Parkinson's Disease Rating Scale. Criteria from the Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised, were applied during a semistructured interview to determine the diagnosis of dementia.
RESULTS: Dementia was found in 67 patients (27.7%). Patients with dementia were older at the time of the study and at onset of PD and had had PD longer than the patients without dementia. Major depression was more common among patients with dementia (23%) than among patients without dementia (2.3%) (chi 2 , P < .001), and patients with dementia were more often institutionalized than those without dementia (62% vs 6%, respectively, chi 2 , P < .001). Atypical neurologic features for idiopathic PD (ie, early occurrence of autonomic failure, symmetrical disease presentation, and only moderate response to a dopamine agonist) were associated with more severe dementia of a higher frequency rate and with lower scores on cognitive rating scales.
CONCLUSION: Approximately one quarter of the patients with PD had dementia with the motor manifestations of PD. Dementia was associated with depression, institutionalization, older age at onset of PD, and atypical neurologic features.

Entities:  

Mesh:

Year:  1996        PMID: 8660156     DOI: 10.1001/archneur.1996.00550060082020

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  43 in total

Review 1.  Neuropsychiatric aspects of Parkinson's disease.

Authors:  D Aarsland; K Karlsen
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

2.  Health related quality of life in Parkinson's disease: a prospective longitudinal study.

Authors:  K H Karlsen; E Tandberg; D Arsland; J P Larsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-11       Impact factor: 10.154

Review 3.  Neuropsychiatry of the basal ganglia.

Authors:  H A Ring; J Serra-Mestres
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-01       Impact factor: 10.154

4.  Donepezil for cognitive impairment in Parkinson's disease: a randomized controlled trial.

Authors:  Karen Marder
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

Review 5.  Evaluating drug treatments for Parkinson's disease: how good are the trials?

Authors:  Keith Wheatley; Rebecca L Stowe; Carl E Clarke; Robert K Hills; Adrian C Williams; Richard Gray
Journal:  BMJ       Date:  2002-06-22

6.  Gene-environment interplay in affect and dementia: emotional modulation of cognitive expression in personal outcomes.

Authors:  T Palomo; R J Beninger; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 7.  Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.

Authors:  Irene Litvan; Jennifer G Goldman; Alexander I Tröster; Ben A Schmand; Daniel Weintraub; Ronald C Petersen; Brit Mollenhauer; Charles H Adler; Karen Marder; Caroline H Williams-Gray; Dag Aarsland; Jaime Kulisevsky; Maria C Rodriguez-Oroz; David J Burn; Roger A Barker; Murat Emre
Journal:  Mov Disord       Date:  2012-01-24       Impact factor: 10.338

8.  Gray matter atrophy in patients with Parkinson's disease and those with mild cognitive impairment: a voxel-based morphometry study.

Authors:  Jing Zhang; Yun-Ting Zhang; Wei-Dong Hu; Li Li; Guang-Yao Liu; Yu-Ping Bai
Journal:  Int J Clin Exp Med       Date:  2015-09-15

9.  Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia.

Authors:  Blanca Ramírez-Ruiz; María José Martí; Eduardo Tolosa; David Bartrés-Faz; Chistopher Summerfield; Pilar Salgado-Pineda; Beatriz Gómez-Ansón; Carme Junqué
Journal:  J Neurol       Date:  2005-07-05       Impact factor: 4.849

Review 10.  Cognitive impairment and dementia in patients with Parkinson disease.

Authors:  James B Leverenz; Joseph F Quinn; Cyrus Zabetian; Jing Zhang; Kathleen S Montine; Thomas J Montine
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.